ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.896,50
-0,14%
S&P 500
5.052,34
0,68%
Dow Jones
38.146,28
0,64%
Euro vs US Dollar
1,0715
-0,03%
Bitcoin
59.044,20
1,38%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Intercept Pharmaceuticals Inc (ICPT)

  7. Intercept Pharmaceuticals Inc (ICPT) News

ICPT Intercept Pharmaceuticals Inc

19,00
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Intercept Pharmaceuticals Inc ICPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 19,00 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
19,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
29.2.202414:30GLOBEIntercept Announces FDA Acceptance of Supplemental New Drug..
20.11.202318:09EDGAR2Form 15-12G - Securities registration termination [Section..
15.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13.11.202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202320:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:00GLOBEIntercept Announces New Phase 2 Data Showing Significant..
10.11.202314:00GLOBEIntercept Announces New Findings from Long-term Extension of..
08.11.202322:44EDGAR2Form 8-K - Current report
08.11.202322:28EDGAR2Form POS AM - Post-Effective amendments for registration..
08.11.202322:21EDGAR2Form S-8 POS - Securities to be offered to employees in..
08.11.202315:21EDGAR2Form 25-NSE - Notification filed by national security..
08.11.202315:13GLOBEAlfasigma completes acquisition of Intercept..
08.11.202313:50EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
08.11.202312:04EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
06.11.202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202314:10EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30.10.202313:49EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
26.10.202315:07EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
26.10.202314:54EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
18.10.202315:02EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
17.10.202323:12EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11.10.202322:34EDGAR2Form SC 14D9 - Solicitation, recommendation statements
11.10.202322:16EDGAR2Form SC TO-T - Tender offer statement by Third Party
10.10.202317:10EDGAR2Form SC TO-C - Written communication relating to an issuer..
28.9.202323:17EDGAR2Form SC14D9C - Written communication relating to third party..
26.9.202323:06EDGAR2Form SC14D9C - Written communication relating to third party..
26.9.202318:43EDGAR2Form SC TO-C - Written communication relating to an issuer..
26.9.202314:28EDGAR2Form 8-K - Current report
26.9.202314:00GLOBEAlfasigma to Acquire Intercept Pharmaceuticals for $19.00..
25.9.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202314:30GLOBEIntercept Pharmaceuticals to Conduct Fireside Chats and..
03.8.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.8.202313:05EDGAR2Form 8-K - Current report
02.8.202313:00GLOBEIntercept Pharmaceuticals Reports Second Quarter 2023..

Kürzlich von Ihnen besucht

NASDAQ
ICPT
Intercept Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten